Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GART | P22102 | 11/20 | 0.88 |
| ▸ | FOLR1 | P15328 | 7/20 | 0.88 |
| ▸ | SLC46A1 | Q96NT5 | 7/20 | 0.88 |
| ▸ | SLC19A1 | P41440 | 6/20 | 0.88 |
| ▸ | TYMS | P04818 | 5/20 | 0.88 |
| ▸ | DHFR | P00374 | 4/20 | 0.88 |
| ▸ | FOLR2 | P14207 | 3/20 | 0.88 |
| ▸ | ATIC | P31939 | 2/20 | 0.88 |
| ▸ | SHMT1 | P34896 | 1/20 | 0.88 |
| ▸ | FRK | P42685 | 1/20 | 0.88 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pemetrexed SCHEMBL7144918 | 0.94 | GART (1.00) | GARTFOLR1SLC46A1SLC19A1TYMS | |
| Pemetrexed SCHEMBL209720 | 0.94 | GART (1.00) | GARTFOLR1SLC46A1SLC19A1TYMS | |
| Pemetrexed SCHEMBL5959741 | 0.94 | GART (1.00) | GARTFOLR1SLC46A1SLC19A1TYMS | |
| Pemetrexed SCHEMBL14321276 | 0.93 | GART (0.98) | GARTFOLR1SLC46A1SLC19A1TYMS | |
| Pemetrexed SCHEMBL1933381 | 0.93 | GART (0.98) | GARTFOLR1SLC46A1SLC19A1TYMS | |
| SCHEMBL22326829 | 0.92 | GART (0.87) | GARTFOLR1SLC46A1SLC19A1TYMS | |
| SCHEMBL17410490 | 0.92 | GART (0.87) | GARTFOLR1SLC46A1SLC19A1TYMS | |
| SCHEMBL7143669 | 0.91 | TYMS (0.89) | GARTFOLR1SLC46A1SLC19A1TYMS | |
| SCHEMBL24846066 | 0.91 | GART (0.93) | GARTFOLR1SLC46A1SLC19A1TYMS | |
| SCHEMBL22967367 | 0.91 | GART (0.93) | GARTFOLR1SLC46A1SLC19A1TYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2997031-A1 | PROCESS FOR THE PREPARATION OF HIGH PURITY AMORPHOUS PEMETREXED DISODIUM AND CRYSTALLINE FORMS OF N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3- D]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID | Instytut Farmaceutyczny (PL) | 2016-03-23 | — | — | EP | disclosed |
| EP-1259513-B1 | A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR | LILLY CO ELI (US) | 2003-09-10 | — | — | EP | disclosed |